Strategic Acquisition USRetina’s assets have been acquired by McKesson, signaling a broader distribution channel and potential cross-sell opportunities for McKesson’s retina solutions, analytics, and GPO capabilities to a larger network of retina practices.

Network scale USRetina claims a large retina practice network with over 300 practices and about 1,200 physicians, offering a substantial base for upsell of technology platforms, practice management tools, and data analytics services.

Analytics & Tech Recent tech initiatives such as RetinaOS and a data-driven operating model present opportunities to market enhanced data analytics, business intelligence, and outcome metrics to practices seeking efficiency and quality improvements.

Growth & Expansion Collaborations with CROs and partnerships noted in recent news indicate potential for expanding clinical trials support, site operations, and registry integrations to attract trial sponsors and researchers.

Financials & Partners Revenue and funding signals a mid-market profile with room for scalable software, managed services, and GPO-driven procurement solutions aligned to mid-sized retina practices and affiliations.